448904-47-0 Desvenlafaxine Succinate 98%

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally.

We offer APIs from a wide range of therapeutic classes like NSAIDS, Antifungals, Antidepressants, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories.

With a strong team of 1100 employees, Amoli has been able to carve out a place for itself in India's booming pharmaceutical industry. With a stellar regulatory track record, Amoli enjoys the reputation of being a preferred and reliable supplier of several APIs.

Our strategy is to keep evolving on all fronts (quality, regulatory and business) in order to remain competitive and relevant in the industry, while ensuring our foundational roots remain intact.